Literature DB >> 4016962

Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis.

H N Claman, B D Jaffee, J C Huff, R A Clark.   

Abstract

We explored the pathologic changes in the skin of mice undergoing a chronic graft-versus-host (GVH) reaction. In rodents and in man, chronic GVH includes the deposition of excess collagen in the skin-a reaction which resembles idiopathic scleroderma. GVH disease across minor histocompatibility barriers was produced by injecting B10.D2 cells into irradiated BALB/c mice. These strains are identical at the H-2 and Mls loci but differ in minor histocompatibility antigens. Control BALB/c mice received irradiation and BALB/c cells. Serial skin biopsies were taken and studied for histological changes characteristic of chronic GVHD, for mast cell density, and for the deposition of immunoreactants. GVHD was produced in B10.D2----BALB/c mice as measured by body weight loss and the production of skin changes including dermal fibrosis, loss of fat and appendages, and a mononuclear cell infiltrate. Dermal mast cells, assessed by toluidine blue staining, were normal at Day 11, but had disappeared by Days 21-63 and returned to normal by Day 104. Immunoglobulins IgG, IgA, and IgM appeared at the dermo-epidermal junction and along the basement membrane zone of hair follicles. This deposition was maximal at Day 42 and waned thereafter. Thus the appearance of immunoglobulins in the skin was maximal when mast cell staining was minimal. The changes in this GVHD model leading to a scleroderma-like picture in the skin are compatible with an immune etiology for the fibrosis. Vasodilation following liberation of mast cell mediators would facilitate the deposition of immunoglobulins. The disappearance of mast cell staining may be caused by extensive degranulation. We postulate an interaction between GVHD-activated T cells, mast cell stimulation, fibroblast activation, and fibrosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016962     DOI: 10.1016/0008-8749(85)90086-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  27 in total

Review 1.  Animal models for scleroderma: an update.

Authors:  Yan Zhang; Anita C Gilliam
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 2.  A unifying hypothesis for scleroderma: identifying a target cell for scleroderma.

Authors:  William M Mahoney; Jo Nadine Fleming; Stephen M Schwartz
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

3.  Role of mast cells and myofibroblasts in human peritoneal adhesion formation.

Authors:  Xiang Xu; Avraham Rivkind; Orit Pappo; Alon Pikarsky; Francesca Levi-Schaffer
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

4.  Separate influences of birth order and gravidity/parity on the development of systemic sclerosis.

Authors:  Tonya Cockrill; Deborah J del Junco; Frank C Arnett; Shervin Assassi; Filemon K Tan; Terry McNearney; Michael Fischbach; Marilyn Perry; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

Review 5.  Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.

Authors:  Kazuyuki Tsujino; Dean Sheppard
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

6.  A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo.

Authors:  P G Schlegel; R Aharoni; Y Chen; J Chen; D Teitelbaum; R Arnon; M Sela; N J Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 7.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

8.  A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).

Authors:  R M Silver; A Ludwicka; M Hampton; T Ohba; S A Bingel; T Smith; R A Harley; J Maize; M P Heyes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 9.  Mouse models of bone marrow transplantation.

Authors:  Pavan Reddy; Robert Negrin; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 10.  Mast cells and immunological skin diseases.

Authors:  Daniel Navi; Jun Saegusa; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.